Self-reported health and survival in older patients diagnosed with multiple myeloma.

被引：0
|
作者：
Nabulsi, Nadia Azmi
Alobaidi, Ali
Talon, Brian
Asfaw, Alemseged Ayele
Zhou, Jifang
Sharp, Lisa K.
Sweiss, Karen
Patel, Pritesh Rajni
Chiu, Brian C-H
Ko, Naomi
Calip, Gregory Sampang
机构：
[1] Univ Illinois, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[2] Univ Illinois, Dept Pharm Practice, Chicago, IL USA
[3] Univ Illinois, Dept Med, Div Hematol & Oncol, Chicago, IL USA
[4] Univ Illinois, Div Epidemiol, Dept Hlth Studies, Chicago, IL USA
[5] Boston Med Ctr, Boston, MA USA
[6] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.6582
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6582
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Self-reported health and mortality in patients with hemophilia
    Plug, I. .
    Van der Bom, J. .
    Rosendaal, F. .
    [J]. HAEMOPHILIA, 2008, 14 : 150 - 151
  • [32] Multimorbidity patterns and their association with survival in a large national cohort of older veterans with multiple myeloma.
    Fillmore, Nathanael
    DuMontier, Clark
    Cheng, David
    Cirstea, Diana
    Yellapragada, Sarvari
    Pyarajan, Saiju
    Nhan Do
    Kim, Dae
    Abel, Gregory A.
    Brophy, Mary T.
    Driver, Jane A.
    Munshi, Nikhil C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Factors influencing self-reported health in Chilean older people
    Alvear, Sandra
    Rodriguez, Patricia
    Riveros, Carolina
    Arenas, Angela
    Canteros, Jorge
    [J]. REVISTA MEDICA DE CHILE, 2019, 147 (11) : 1407 - 1414
  • [34] MYELOMA CAST NEPHROPATHY, LIGHT CHAIN DEPOSITION DISEASE, AND BOTH IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.
    Lin, Zishan
    Yu, Xiaojuan
    Wang, Suxia
    Zhou, Fude
    Zhao, Minghui
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 599 - 599
  • [35] Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.
    Siragusa, Sergio
    Morice, William
    Gertz, Morie A.
    Kyle, Robert
    Greipp, Philip R.
    Lust, John A.
    Witzig, Thomas E.
    Lacy, Martha Q.
    Zeldenrust, Steven R.
    Rajkumar, S. Vincent
    Hayman, Suzanne R.
    Buadi, Francis
    Russell, Stephen J.
    Kumar, Shaji
    Dingli, David
    Dispenzieri, Angela
    [J]. BLOOD, 2009, 114 (22) : 1096 - 1096
  • [36] Impact of age on survival after intensive therapy in newly diagnosed multiple myeloma. The Nordic myeloma study group (NMSG).
    Lenhoff, S
    Hjorth, M
    Gimsing, P
    Tangen, JM
    Westin, J
    [J]. BLOOD, 2004, 104 (11) : 264A - 265A
  • [37] Peripheral blood myeloma cells as a prognostic factor for survival in patients with new, untreated multiple myeloma.
    Witzig, TE
    Gertz, MA
    Lust, JA
    Kyle, RA
    OFallon, WM
    Greipp, PR
    [J]. BLOOD, 1995, 86 (10) : 217 - 217
  • [38] VASP chemotherapy in patients with multiple myeloma.
    Vidarsson, B
    Olafsdottir, S
    Reykdal, S
    [J]. BLOOD, 2005, 106 (11) : 381B - 381B
  • [39] Racial differences in intravenous bisphosphonate utilization among older patients with multiple myeloma.
    Zhou, Jifang
    Sweiss, Karen
    Patel, Pritesh Rajni
    Nutescu, Edith
    Ko, Naomi
    Chiu, Brian C-H
    Calip, Gregory Sampang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Understanding health outcome preferences of older adults diagnosed with multiple myeloma
    Maheshwari, Supriya
    Arias, Miguel
    Ubersax, Clare
    Tucker, Abigail
    Bal, Susan
    Ravi, Gayathri
    Godby, Kelly
    Costa, Luciano J.
    Williams, Grant R.
    Shrestha, Sadeep
    Bhatia, Smita
    Giri, Smith
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (05)
12345